HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Downregulation of miRNA-30a enhanced autophagy in osthole-alleviated myocardium ischemia/reperfusion injury.

Abstract
Osthole could alleviate myocardial ischemia/reperfusion (I/R) injury. However, the underlying mechanism remains unclear. In this study, we explored whether microRNA (miR)-30a and its target autophagy marker Beclin-1 involved in the osthole protective role in the rat and cells myocardial I/R injury models. The myocardial damages including increases in myocardial collagen content and cell apoptosis in I/R injury model were observed by Masson's Trichrome Staining and terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assays. Osthole significantly inhibited the myocardial damages. Osthole inhibited the induction of miR-30a expression by I/R in rat and hypoxia/reoxygenation (H/R) in myocardial cells. After knockdown, the expression of miR-30a by miR-30a inhibitor, H/R induced cell apoptosis was significantly inhibited. The level of Beclin-1 expression and ratio of LC3BII/LC3BI were inhibited by I/R in rat and H/R in myocardial cells, whereas osthole significantly increased them. Knockdown of miR-30a significantly upregulated the Beclin-1 expression and ratio of LC3BII/LC3BI. Inhibition of autophagy by 3-MA significantly reversed the protective role of osthole in H/R myocardial cell. Therefore, we concluded that the mechanism by which osthole alleviate myocardial I/R injury may be achieved by enhancing the autophagy partially via inhibiting the expression of miR-30a.
AuthorsShengzhong Liu, Ying He, Jun Shi, Lulu Liu, Hao Ma, Li He, Yingqiang Guo
JournalJournal of cellular physiology (J Cell Physiol) (Apr 24 2019) ISSN: 1097-4652 [Electronic] United States
PMID31017665 (Publication Type: Journal Article)
Copyright© 2019 Wiley Periodicals, Inc.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: